CareDx, Inc (CDNA)
USD 15.0
(-0.46%)
USD 15.0
(-0.46%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 34.22 Million USD | -12.25% |
| 2022 | 38.99 Million USD | 124.2% |
| 2021 | 17.39 Million USD | 8.25% |
| 2020 | 16.06 Million USD | 432.62% |
| 2019 | 3.01 Million USD | 1654.07% |
| 2018 | 172 Thousand USD | -99.49% |
| 2017 | 34.05 Million USD | 42.24% |
| 2016 | 23.94 Million USD | 52.0% |
| 2015 | 15.75 Million USD | 38.04% |
| 2014 | 11.41 Million USD | -25.98% |
| 2013 | 15.41 Million USD | 3.32% |
| 2012 | 14.92 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 31.44 Million USD | -4.55% |
| 2024 Q3 | 23.84 Million USD | -4.72% |
| 2024 Q1 | 32.94 Million USD | -3.72% |
| 2023 Q1 | 32 Million USD | -17.93% |
| 2023 Q3 | 35.21 Million USD | -3.26% |
| 2023 Q2 | 36.39 Million USD | 13.72% |
| 2023 FY | 34.22 Million USD | -12.25% |
| 2023 Q4 | 34.22 Million USD | -2.81% |
| 2022 Q2 | 19.05 Million USD | -6.72% |
| 2022 Q1 | 20.42 Million USD | 17.43% |
| 2022 FY | 38.99 Million USD | 124.2% |
| 2022 Q4 | 38.99 Million USD | -2.31% |
| 2022 Q3 | 39.92 Million USD | 109.52% |
| 2021 Q4 | 17.39 Million USD | -19.84% |
| 2021 Q2 | 21.14 Million USD | -2.05% |
| 2021 Q3 | 21.69 Million USD | 2.61% |
| 2021 FY | 17.39 Million USD | 8.25% |
| 2021 Q1 | 21.58 Million USD | 34.35% |
| 2020 Q2 | 18.75 Million USD | -1.65% |
| 2020 FY | 16.06 Million USD | 432.62% |
| 2020 Q4 | 16.06 Million USD | -12.72% |
| 2020 Q1 | 19.07 Million USD | 532.18% |
| 2020 Q3 | 18.41 Million USD | -1.85% |
| 2019 Q2 | 2.03 Million USD | -0.29% |
| 2019 Q4 | 3.01 Million USD | 48.4% |
| 2019 FY | 3.01 Million USD | 1654.07% |
| 2019 Q3 | 2.03 Million USD | -0.05% |
| 2019 Q1 | 2.04 Million USD | 1086.05% |
| 2018 Q4 | 172 Thousand USD | -98.73% |
| 2018 Q3 | 13.55 Million USD | 0.57% |
| 2018 Q2 | 13.47 Million USD | 31.28% |
| 2018 Q1 | 10.26 Million USD | -69.86% |
| 2018 FY | 172 Thousand USD | -99.49% |
| 2017 FY | 34.05 Million USD | 42.24% |
| 2017 Q4 | 34.05 Million USD | -5.92% |
| 2017 Q3 | 36.2 Million USD | 6.71% |
| 2017 Q2 | 33.92 Million USD | 4.62% |
| 2017 Q1 | 32.42 Million USD | 35.44% |
| 2016 Q3 | 26.39 Million USD | -8.64% |
| 2016 Q4 | 23.94 Million USD | -9.3% |
| 2016 FY | 23.94 Million USD | 52.0% |
| 2016 Q1 | 15.85 Million USD | 0.62% |
| 2016 Q2 | 28.89 Million USD | 82.31% |
| 2015 Q3 | 15.79 Million USD | 0.16% |
| 2015 Q2 | 15.76 Million USD | 0.25% |
| 2015 FY | 15.75 Million USD | 38.04% |
| 2015 Q1 | 15.72 Million USD | 37.83% |
| 2015 Q4 | 15.75 Million USD | -0.27% |
| 2014 Q4 | 11.41 Million USD | -10.34% |
| 2014 Q3 | 12.72 Million USD | -32.2% |
| 2014 Q2 | 18.77 Million USD | 24.2% |
| 2014 Q1 | 15.11 Million USD | -1.97% |
| 2014 FY | 11.41 Million USD | -25.98% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 15.41 Million USD | 3.32% |
| 2013 Q4 | 15.41 Million USD | 0.0% |
| 2012 FY | 14.92 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 426 Thousand USD | -7933.099% |
| Applied DNA Sciences, Inc. | 1.23 Million USD | -2664.752% |
| Aspira Women's Health Inc. | 2.26 Million USD | -1410.194% |
| Biodesix, Inc. | 60.69 Million USD | 43.614% |
| BioNexus Gene Lab Corp. | 133.39 Thousand USD | -25553.885% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -2067.753% |
| bioAffinity Technologies, Inc. | 1.57 Million USD | -2067.753% |
| Bionano Genomics, Inc. | 87.94 Million USD | 61.089% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 15.31 Million USD | -123.521% |
| DarioHealth Corp. | 29.54 Million USD | -15.842% |
| Exact Sciences Corporation | 2.55 Billion USD | 98.66% |
| Fulgent Genetics, Inc. | 14.9 Million USD | -129.563% |
| Guardant Health, Inc. | 1.35 Billion USD | 97.472% |
| ICON Public Limited Company | 3.93 Billion USD | 99.131% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 96.39% |
| Illumina, Inc. | 2.26 Billion USD | 98.487% |
| Intelligent Bio Solutions Inc. | 871.44 Thousand USD | -3826.948% |
| iSpecimen Inc. | 196.24 Thousand USD | -17337.985% |
| Standard BioTools Inc. | 98.21 Million USD | 65.155% |
| MDxHealth SA | 41.26 Million USD | 17.07% |
| 23andMe Holding Co. | 76.51 Million USD | 55.275% |
| Medpace Holdings, Inc. | 142.12 Million USD | 75.921% |
| Myriad Genetics, Inc. | 145 Million USD | 76.399% |
| Mainz Biomed B.V. | 7.42 Million USD | -361.151% |
| ENDRA Life Sciences Inc. | 394.4 Thousand USD | -8576.658% |
| NeoGenomics, Inc. | 611.67 Million USD | 94.405% |
| Neogen Corporation | 906.23 Million USD | 96.224% |
| Inotiv, Inc. | 417.64 Million USD | 91.806% |
| Natera, Inc. | 441.99 Million USD | 92.258% |
| OPKO Health, Inc. | 326.56 Million USD | 89.521% |
| Psychemedics Corporation | 2.29 Million USD | -1389.164% |
| Prenetics Global Limited | 2.36 Million USD | -1344.297% |
| Prenetics Global Limited | 2.36 Million USD | -1344.297% |
| Precipio, Inc. | 1.11 Million USD | -2966.398% |
| Personalis, Inc. | 48.96 Million USD | 30.107% |
| RadNet, Inc. | 1.49 Billion USD | 97.705% |
| Sera Prognostics, Inc. | 1.85 Million USD | -1741.819% |
| Sotera Health Company | 2.32 Billion USD | 98.529% |
| Neuronetics, Inc. | 62.47 Million USD | 45.224% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -848.213% |
| Star Equity Holdings, Inc. | 3.6 Million USD | -848.213% |
| Trinity Biotech plc | 67.42 Million USD | 49.247% |
| Twist Bioscience Corporation | 94.06 Million USD | 63.621% |
| Exagen Inc. | 23.72 Million USD | -44.265% |